🚨 Exciting news: Abstract Submission for #ADPD2026 is Now Open!. Submit your research, share your insights and help shape the future of neurodegenerative disease research and care. 🔍 Explore over 200+ abstract topics and start preparing your submission today. ➡️

📰Can a Pen Powered by AI Detect Parkinson’s? | @alzforum. “@Parkinsons disease (PD) is the second most common neurodegenerative disorder, after Alzheimer’s. Clinicians often use the mnemonic TRAP to recall its four key motor symptoms: tremor, rigidity, akinesia/bradykinesia, and

🔍 Missed our latest video on multimodal interventions for early stage #Alzheimers? Here’s why you should watch:. ✔️ Real-world insights from participants.✔️ Evidence-backed strategies combining lifestyle & medical nutrition.✔️ A closer look at how prevention can reshape

Discover the crucial connection between #vascular health and #neurodegenerative diseases at #ADPD2026!. Vascular dysfunction is key in the development and progression of Alzheimer's, Parkinson's, and other related disorders. We invite researchers to explore this important topic

🎧 New AD/PD™ Session Spotlight out now!. Forum Discussion 03 from the AD/PD™ 2025 International Conference: “Improving the Therapeutic Potential of Immunotherapies in AD – Can Novel Strategies or Next Generation Drugs Halt or Further Delay Disease Progression?". Chaired by Dr.

🎥 Reminder: All sessions from the AD/PD™ 2025 International Conference are available on demand through the UNLOK virtual platform for all registered Gold Track participants! . Dive back into cutting-edge research, clinical insights, and global discussions, all from the

🎧 New AD/PD™ Session Spotlight out now!. In this episode, we explore Plenary Lecture 2 from #ADPD2025: “GLP-1R Agonist Effects in Brain.”. Moderated by Dr. Cynthia Lemere | @clemere99 and Dr. Henrietta Nielsen, this featured lecture was presented by Dr. Lotte Bjerre Knudsen

Share your findings at AD/PD™ 2026!. Be part of the conversation in Copenhagen, Denmark, and contribute to the global effort to understand and combat neurodegenerative diseases. 📆 Abstract Submission Deadline: September 10, 2025. Submit your abstract here: 🔗

The application for AD/PD™ 2026 Junior Faculty Awards is open! . If you're an early-career researcher eager to make your mark, this is your chance to shine. Submit your application by September 17, 2025, to be considered for this prestigious recognition and join us in

🧠 Discover how a multimodal intervention—combining lifestyle changes with medical food—can improve outcomes for older adults at risk of #Alzheimers. 🎥 Watch this video to explore: ✔️ Key findings from a recent study.✔️ Real participant feedback.✔️ The

Dive deep into the world of Parkinson's disease, multiple system atrophy, and other #synucleinopathies. Join us in advancing the understanding and treatment of these complex disorders. Submit your abstracts by September 10, 2025, and be a part of the discussion at #ADPD2026!🔗

📢 Last Call!.You still have time to secure your spot for tomorrow's AD/PD™ Journal Club!. 📅 When: 1 July at 16:00 CEST.🎤 Prof. George Perry and Prof. David Libon.👉 REGISTER NOW: Bonus: FREE access to the featured publication for all attendees:

📰 Could Monocyte-Derived Microglia Cause Some Cases of Parkinsonism? . “Microglia in the brain’s parenchyma arise from macrophage progenitors in the embryonic yolk sac and are thought to self-renew locally during a mammal’s lifespan, without macrophages from the hematopoietic

Meet Prof. David J. Libon, Ph.D. at the upcoming AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"!. 📅 When: 1 July at 16:00 CEST.🎤 Prof. George Perry and Prof. David Libon.👉 REGISTER NOW: 📖

Share your cutting-edge research on tauopathies for #ADPD2026!💡. Join the global effort to unravel the complexities of tau-related #neurodegeneration and drive forward innovative treatments. Submit your abstracts now➡️  .#ADPD #alzheimers #dementia

🧠 Join our FREE AD/PD™ Webinar: Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression 🧠. 📅 26 June 2025 | 10:00 EST, 16:00 CEST.🔍Explore amyloid-tau dynamics in AD with Dr. Niklas Mattsson-Carlgren, of Lund University and a live Q&A with Dr. Holly

🎧 New AD/PD™ Session Spotlight out now!. In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — "Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and #AI in MCI & AD.". Moderated by

📰 Do PERK’d Up Astrocytes Slow Amyloid Clearance? | @alzforum . “Cells feature an array of biological cascades to respond to stressors such as protein aggregates, viruses, and #DNA damage. When these pathways are activated too much or for too long, things can go awry. This may

Meet Prof. George Perry at the next AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"!. 📅 When: 1 July at 16:00 CEST.🎤 Prof. George Perry and Prof. David Libon.👉 REGISTER NOW: 📖 Bonus: FREE

We're inviting researchers to submit abstracts on β-Amyloid Diseases for #ADPD2026! . Share your innovative findings and insights with the global #neuroscience community. This is your chance to contribute to advancing neurodegenerative disease research and make a lasting

🧠 Join the Next AD/PD™ Live Journal Club of 2025!. Discover how subtle behavioral cues, like response time—even when test scores seem normal—may help detect early signs of Alzheimer’s and other dementias. Topic: "Precision Neurocognition: A New Diagnostic Paradigm in